Taysha Gene Therapies, Inc. Prepaid Expense and Other Assets, Current
Taysha Gene Therapies, Inc. (TSHA) had Prepaid Expense and Other Assets, Current of $6.03 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-11
- 2026-06-30: Prepaid Expense and Other Assets, Current $6.03M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $5.22M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $4.43M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $2.16M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $6.03M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $5.22M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $4.43M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $2.16M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $3.05M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $3.67M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.65M 10-K · filed 2026-03-19 |
| 2024-09-30 | $3.42M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.28M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $4.17M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.48M 10-K · filed 2025-02-26 |
| 2023-09-30 | $5.53M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $9.03M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $8.93M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.54M 10-K · filed 2024-03-19 |
| 2022-09-30 | $8.70M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $10.60M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10.26M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $10.50M 10-K · filed 2023-03-28 |
| 2021-09-30 | $8.38M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $9.93M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $10.82M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.63M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |